← Back to Clinical Trials
Recruiting NCT06673732

NCT06673732 Effects of Muscle Energy Technique With and Without Stationary Cycling on Toe Walking With ASD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06673732
Status Recruiting
Phase
Sponsor Riphah International University
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 26 participants
Start Date 2024-09-26
Primary Completion 2025-01-07

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age 10 Years
Study Type INTERVENTIONAL
Interventions
Muscle Energy Technique with Stationary Bi-CyclyingMuscle Energy Technique without Stationary Cycling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 26 participants in total. It began in 2024-09-26 with a primary completion date of 2025-01-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In Autism spectrum disorder (ASD) is a developmental disability caused by differences in the brain. People with ASD often have problems with social communication and interaction, and restricted or repetitive behaviors or interests. People with ASD may also have different ways of learning, moving, or paying attention. The Aim of this thesis is Effects of Muscle Energy Technique with and without Stationary Cycling on toe walking children with Autism Spectrum Disorder This study seeks to explore whether the synergistic application of these interventions can provide a more comprehensive and effective approach in managing the debilitating symptoms associated with toe walking in Autistic children.

Eligibility Criteria

Inclusion Criteria: * Children with diagnosed Autism . * Aged between 4 to 10 years. * Autistic children with Toe-Walking * Regular for follow-up * Both Gender included Exclusion Criteria: * Children with Comorbidities . * Children with mild cognitive dysfunction * Children less then 4 year or older than 10 years.. * Autistic Children with limb deformity * Autistic Children with Mental Retardation.

Contact & Investigator

Central Contact

Imran Amjad, PhD

✉ Imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

Rna Mohammad Iqbal, MS*

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06673732 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, up to 10 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06673732 currently recruiting?

Yes, NCT06673732 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT06673732 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06673732 clinical trial?

NCT06673732 is sponsored by Riphah International University. The principal investigator is Rna Mohammad Iqbal, MS* at Riphah International University. The trial plans to enroll 26 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology